Exploring the effect of BRCA1/2 status on chemotherapy-induced hematologic toxicity in patients with ovarian cancer. - Lee IH; Lee SJ; Kim J; Lee YH; Chong GO; Kim JM; Lee J; Lee NY; Park SY; Hong DG; Chae YS (Cancer chemotherapy and pharmacology, 2024)